Conde-Sieira M, Bonacic K, Velasco C, Valente LM, Morais S, Soengas JL. Hypothalamic fatty acid sensing in Senegalese sole (Solea senegalensis): response to long-chain saturated, monounsaturated, and polyunsaturated (n-3) fatty acids. Am J Physiol Regul Integr Comp Physiol 309: R1521-R1531, 2015. First published October 14, 2015 doi:10.1152/ajpregu.00386.2015We assessed the presence of fatty acid (FA)-sensing mechanisms in hypothalamus of Senegalese sole (Solea senegalensis) and investigated their sensitivity to FA chain length and/or level of unsaturation. Stearate (SA, saturated FA), oleate (OA, monounsaturated FA of the same chain length), ␣-linolenate [ALA, a n-3 polyunsaturated fatty acid (PUFA) of the same chain length], and eicosapentanoate (EPA, a n-3 PUFA of a larger chain length) were injected intraperitoneally. Parameters related to FA sensing and neuropeptide expression in the hypothalamus were assessed after 3 h and changes in accumulated food intake after 4, 24, and 48 h. Three FA sensing systems characterized in rainbow trout were also found in Senegalese sole and were activated by OA in a way similar to that previously characterized in rainbow trout and mammals. These hypothalamic FA sensing systems were also activated by ALA, differing from mammals, where n-3 PUFAs do not seem to activate FA sensors. This might suggest additional roles and highlights the importance of n-3 PUFA in fish diets, especially in marine species. The activation of FA sensing seems to be partially dependent on acyl chain length and degree of saturation, as no major changes were observed after treating fish with SA or EPA. The activation of FA sensing systems by OA and ALA, but not SA or EPA, is further reflected in the expression of hypothalamic neuropeptides involved in the control of food intake. Both OA and ALA enhanced anorexigenic capacity compatible with the activation of FA sensing systems. Senegalese sole; hypothalamus; polyunsaturated fatty acid; fatty acid sensing; food intake THIS STUDY FOCUSES ON THE metabolic control of food intake in the hypothalamus. This term refers to the capacity of specific neurons located in the hypothalamus to detect changes in the levels of metabolites, such as glucose or fatty acids through nutrient-sensing mechanisms (8, 10, 31) . When the levels of nutrients rise, this increase is detected through nutrient sensing mechanisms in these neurons, and as a result, one of the populations (the so-called glucose-excited, GE neurons) is stimulated, resulting in increased release of the neuropeptides proopiomelanocortin (POMC) and cocaine-and amphetamineregulated transcript (CART) synthesized by these neurons. In contrast, the other population (the so-called glucose-inhibited, GI neurons) is inhibited, resulting in decreased release of the neuropeptides Agouti-related peptide (AgRP) and neuropeptide Y (NPY) synthesized by these neurons (8, 10, 31). The global balance of the response is an increased anorectic potential and subsequent decrease in food intake. Conversely, when the levels of nutrients decline, the nutrient-sensing systems are inhibited, resulting in increased production of AgRP/NPY and decreased production of POMC/CART, resulting in increased food intake (8, 10, 31). The nutrient sensing mechanisms characterized so far in mammals (8, 10, 31) and fish (44) include both different types of glucosensors and fatty acid sensing mechanisms.
THIS STUDY FOCUSES ON THE metabolic control of food intake in the hypothalamus. This term refers to the capacity of specific neurons located in the hypothalamus to detect changes in the levels of metabolites, such as glucose or fatty acids through nutrient-sensing mechanisms (8, 10, 31) . When the levels of nutrients rise, this increase is detected through nutrient sensing mechanisms in these neurons, and as a result, one of the populations (the so-called glucose-excited, GE neurons) is stimulated, resulting in increased release of the neuropeptides proopiomelanocortin (POMC) and cocaine-and amphetamineregulated transcript (CART) synthesized by these neurons. In contrast, the other population (the so-called glucose-inhibited, GI neurons) is inhibited, resulting in decreased release of the neuropeptides Agouti-related peptide (AgRP) and neuropeptide Y (NPY) synthesized by these neurons (8, 10, 31) . The global balance of the response is an increased anorectic potential and subsequent decrease in food intake. Conversely, when the levels of nutrients decline, the nutrient-sensing systems are inhibited, resulting in increased production of AgRP/NPY and decreased production of POMC/CART, resulting in increased food intake (8, 10, 31) . The nutrient sensing mechanisms characterized so far in mammals (8, 10, 31) and fish (44) include both different types of glucosensors and fatty acid sensing mechanisms.
Fatty acid (FA) sensing mechanisms detect increases in plasma concentration of long-chain fatty acids (LCFA) through several processes (8, 10, 31) , including 1) FA metabolism through inhibition of carnitine palmitoyltransferase 1 (CPT-1) that imports FA-CoA into the mitochondria for oxidation; 2) binding to FA translocase (FAT/CD36) and modulation of transcription factors like peroxisome proliferator-activated receptor type ␣ and sterol regulatory element-binding protein type 1c (SREBP1c); 3) activation of protein kinase C-; and 4) mitochondrial production of reactive oxygen species by electron leakage, resulting in an inhibition of ATP-dependent inward rectifier potassium channel (K ATP ) activity (8, 10, 31) . The 18 carbon monounsaturated FA (MUFA) oleate (OA; C18:1 n-9) is the most studied LCFA in mammals that typically activates all of these systems (8, 10, 31) . However, the ability of different types of LCFA, differing in acyl chain length or degree of unsaturation, to elicit the activation of these systems has been scarcely assessed to date. Fatty acid unsaturation appears to be important since the saturated FA palmitate (C16:0) does not seem to activate hypothalamic FA sensing systems (15, 41, 43) . Moreover, the presence of more than one double bond does not seem to induce comparable activations of FA sensing systems in mammals, as demonstrated by studies carried out with linoleate (C18:2 n-6) (39) or docosahexanoate (DHA; C22:6 n-3) (12, 13, 41) , although no studies that we are aware of have examined both FAs in parallel.
Appetite regulation in fish is a complex process in which the hypothalamus integrates metabolic and endocrine information to elicit changes in food intake through modulation of neuropeptide synthesis and release (44, 48, 49) . As for the regulation of food intake elicited by the sensing of changes in circulating concentrations of FA, we have characterized the presence and function of FA sensing systems in the hypothalamus of the freshwater species rainbow trout (Oncorhynchus mykiss) (23) (24) (25) (26) (27) (28) (29) (30) . These systems responded to changes in the levels of not only LCFA such as OA but, unlike mammals, also to mediumchain FA (MCFA) like octanoate (23) (24) (25) (26) (27) (28) (29) (30) . The activation of these systems was associated with an upregulation of the expression of anorexigenic neuropeptides and food intake as in mammalian species (22, 26) . To date, the presence of FA sensing systems in other fish species has never been investigated.
All vertebrate species have absolute dietary requirements for certain polyunsaturated FAs (PUFAs), which are termed essential fatty acids since they cannot be synthesized de novo and are required for normal body functioning (42) . On the other hand, lipids in aquatic food webs are rich in PUFA, and in marine environments, fish diets are particularly rich in longchain PUFA (42) . Furthermore, PUFA of the n-6 and particularly n-3 series are predominant in tissues of most fish, but especially in marine species (38, 45) . The brain of marine fish is particularly rich in n-3 PUFA, mainly in ␣-linolenate (C18:3 n-3), eicosapentanoate (C20:5 n-3), and DHA (C22:6 n-3) (4, 46) . Therefore, it is interesting to assess whether fish hypothalamic FA sensing systems, particularly in marine species, could differ from those of mammals in the ability to sense changes in levels of these PUFA.
With this in mind, we wanted to investigate the presence of FA sensing systems in the hypothalamus of a marine fish species. Moreover, we also aimed to know whether the ability of hypothalamic FA sensing might vary as a function of LCFA chain length and/or degree of unsaturation. As a model marine fish species, we used a lean flatfish, the Senegalese sole (Solea senegalensis Kaup). The choice of Senegalese sole as a model species for this study had both academic and commercial reasons. More specifically, we selected this marine species because 1) it has high commercial interest, and therefore, studying the physiology of its feeding is important for aquaculture, and 2) its lipid nutrition has been quite well studied, due to its particular nutritional physiology and metabolism, as it concerns lipid and fatty acid requirements: it does not perform well with high lipid levels in the diet and has unique capacities to biosynthesize PUFAs (7, 34) . To achieve these objectives, we injected intraperitoneally 1) stearate (SA; C18: 0)-a saturated FA; 2) oleate (OA, C18:1 n9)-a MUFA of the same chain length, which has been demonstrated to activate FA sensing systems and to modulate food intake in rainbow trout (22, 26) ; 3) ␣-linolenate (ALA; C18:3 n-3), an n-3 PUFA of the same chain length; and 4) eicosapentanoate (EPA; C20:5 n-3)-an n-3 PUFA of a longer chain length and a higher degree of unsaturation. We then evaluated food intake and the hypothalamic mRNA abundance of neuropeptides related to the metabolic control of food intake, such as agrp, npy, pomc, and cart. Furthermore, variables related to putative FA sensing systems were also evaluated on the basis of 1) FA metabolism, such as activities of ATP-citrate lyase (ACLY) and CPT-1, and mRNA abundance of acetyl-CoA carboxylase (acc), acly, cpt1c, and fatty acid synthase (fas); 2) binding to FAT/CD36 and subsequent modulation of transcription factors, such as mRNA abundance of fat/cd36, liver X receptor ␣ (lxr␣), ppar␣, and srebp1c; and, 3) mitochondrial activity, such as 3-hydroxyacylCoA dehydrogenase (HOAD) activity, and mRNA abundance of inward rectifier K ϩ channel pore type 6.x (kir6.x) and sulfonylurea receptor (sur). We have evaluated mRNA abundance of neuropeptides and not protein levels because appropriate antibodies for Western blot analysis were not available in Senegalese sole at the time this study was carried out.
MATERIALS AND METHODS

Fish
Senegalese sole obtained from a commercial fish farm (Aquacria Piscícolas, Aveiro, Portugal) were kept under quarantine conditions for a 3-wk period. The fish were then individually weighed (88.3 Ϯ 1.5 g), measured, and distributed (17 fish per tank in the first phase of the experiment, and 8 fish per tank in the second phase of the experiment) among fiberglass rectangular tanks (0.5 m ϫ 0.4 m) in a closed recirculation system. The system was supplied with filtered and heated (20. Experimental design. Following a 2-wk acclimation period, the first phase of the experiment was carried out. We used a total number of 170 fish. These fish were randomly divided into five groups (control, SA, OA, ALA, or EPA) of 34 fish each. Each treatment was carried out in duplicate tanks (two replicate tanks per treatment), and each tank contained 17 fish. Fish were fasted for 24 h before the experiment to ensure that basal hormone levels were achieved, and then fish were anesthetized with MS-222 (75 mg/l; Sigma, St. Louis, MO), weighed and injected (10 ml/kg ip) with saline solution alone (control) or containing SA, OA, ALA, or EPA (all from Sigma Chemical) at a dose of 300 g/kg. The FA dose was selected on the basis of previous studies carried out in rainbow trout (20) and in preliminary experiments carried out in Senegalese sole (data not shown). To safely deliver the FAs, they were solubilized in 45% hydroxypropyl-␤-cyclodextrin (HBP; Sigma) to a final concentration of 17 mM (36) . The HPB-FA solution was diluted in saline to the appropriate concentration used for each injection. HPB was also added in the control group at a similar concentration to the remaining treatments. Three hours after intraperitoneal injection (established on the basis of previous unpublished results), fish were lightly anesthetized with MS-222 (75 mg/l) and sampled. Blood was collected by caudal puncture with ammonium-heparinized syringes, and plasma samples were obtained after blood centrifugation, then deproteinized (using 0.6 M perchloric acid) and neutralized (using 1 M potassium bicarbonate) before storage at Ϫ80°C until analysis. Fish were killed by decapitation and dissected to remove the hypothalamus, which was snap-frozen in dry ice and stored at Ϫ80°C. At each time point, in each tank, six fish were used to assess enzyme activities and metabolite levels, eight fish were used to evaluate the hypothalamic FA profile, and the remaining three fish were used for assessment of mRNA levels by RT-quantitative PCR. Because we used replicate tanks for each experimental group, we had 12 fish for the assessment of metabolite levels and enzyme activities, 16 fish for the assessment of FA profile, and 6 fish for the assessment of mRNA abundance. For molecular analysis, samples of hypothalamus were collected in tubes containing 0.5 ml of RNAlater stabilization buffer (Sigma) and were kept in agitation at 4°C for 24 h, before storing at Ϫ80°C.
In the second phase of the experiment, we used 160 fish. The fish were divided into five treatment groups of 32 fish each (as described above). Each treatment was carried out in fish of four tanks (four replicate tanks per treatment), and each tank contained eight fish. Fish were fed by hand twice per day (0900 and 1700) to satiety during 3 wk. Food intake was quantified for 3 days before intraperitoneal injection (to collect baseline data) and then 4, 24 and 48 h after an intraperitoneal treatment with pure saline-HPB or containing SA, OA, ALA, or EPA, as described above. After each meal, any remaining uneaten pellets were removed from the tanks. The amount of feed consumed in each tank was calculated as the difference between the number of offered and uneaten pellets. Results are shown as means Ϯ SE of the data obtained in four tanks per treatment.
Assessment of metabolite levels and enzyme activities. Levels of total FA and triglycerides in plasma, were determined enzymatically using commercial kits (Wako Chemicals, Neuss, Germany and Spinreact, Barcelona, Spain; respectively), following manufacturer's instructions, adapted to a microplate format.
Samples used to assess hypothalamic metabolite levels were homogenized immediately by ultrasonic disruption in 5.5 vols of icecooled 0.6 M perchloric acid and were neutralized (using 1 M potassium bicarbonate). The homogenate was centrifuged (10,000 g), and the supernatant was used to assay tissue metabolites. Hypothalamic FA and triglyceride levels were determined enzymatically using commercial kits, as described above for plasma samples.
Samples for evaluation of enzyme activity were homogenized by ultrasonic disruption with 7 vols of ice-cold-buffer consisting of 50 mM Tris (pH 7.6), 5 mM EDTA, 2 mM 1,4-dithiothreitol, and a protease inhibitor cocktail (Sigma). The homogenate was centrifuged (900 g), and the supernatant was used immediately for enzyme assays. Enzyme activities were determined using the INFINITE 200 Pro microplate reader (Tecan, Männedorf, Switzerland). Reaction rates of enzymes were determined by the increase or decrease in absorbance of NAD(P)H at 340 nm or, in the case of CPT-1 activity, of 5,5=-dithiobis(2-nitrobenzoic acid)-CoA complex at 412 nm. The reactions were started by the addition of sample supernatant (10 -15 l) at a preestablished protein concentration, omitting the substrate in control wells (final volume 275-295 l) and allowing the reactions to proceed at 20°C for preestablished times (10 -25 min). Enzyme activities are expressed in terms of milligrams of protein. Protein was assayed in triplicate in homogenates using microplates, according to the bicinchoninic acid method with BSA (Sigma) as a standard. Enzyme activities were assessed at maximum rates by preliminary tests to determine optimal substrate concentrations. ACLY (EC 4.1.3.8), HOAD (EC 1.1.1.35), and CPT-1 (EC 2.3.1.21) activities were determined by adapting previously described methods (22) .
Determination of total lipids and FA profile in the hypothalamus. To have enough tissue mass for the analysis of FA profile in the hypothalamus, the 16 fish sampled for this purpose from each treatment group were grouped into 4 pools of 4 fish each. In each pool, total lipids in the hypothalamus were extracted by chloroform/methanol (2:1, vol/vol) according to Folch et al. (12) and quantified gravimetrically after evaporation of the solvent under nitrogen flow followed by vacuum desiccation overnight. Total lipids were resuspended at 20 mg/ml in chloroform/methanol (2:1) containing 0.01% butylated hydroxytoluene and 100 l subjected to acid-catalyzed transesterification with 21:0 internal standard (9) . Fatty acid methyl ester was extracted using isohexane/diethyl ether (1:1, vol/vol), purified by TLC (Silica gel 60; VWR, Lutterworth, UK) and analyzed by gas-liquid chromatography on a Thermo Electron-Trace GC (Winsford, UK) instrument fitted with a BPX70 capillary column (30 m ϫ 0.25 mm ID; SGE Analytical Science, Chester, UK), using a twostage thermal gradient initially at 40°C/min from 50°C (injection temperature) to 150°C and then to 250°C at 2°C/min. Helium (1.2 ml/min constant flow rate) was used as the carrier gas and on-column injection, and flame ionization detection was performed at 250°C. FAs were identified by comparison with known standards (Supelco, Spain) and a well-characterized fish oil (MARINOL, Stepan Specialty Products, Anaheim, CA) and quantified using Chrom-card for Windows (TraceGC, Thermo Finnigan, Milan, Italy). Primer design. Search for selected candidate genes was performed in the SoleaDB database (3) (http://www.juntadeandalucia.es/ agriculturaypesca/ifapa/soleadb_ifapa/) using the Solea senegalensis v4.1 global assembly. The retrieved transcripts were aligned and assembled in silico using the BioEdit Sequence Alignment Editor and, in some cases, completed with rapid amplification of cDNA ends (RACE) PCR using the FirstChoice RLM-RACE kit (Ambion, Life Technologies, Alcobendas, Madrid, Spain), and the resulting fragments were sequenced (Servei Central de Suport a la Investigació Experimental, University of Valencia, Valencia, Spain). Primers for quantitative RT-PCR were designed with Primer3 v. 0.4.0 (18, 47) (Table 1 ) and the resulting amplicons were sequenced to confirm their identity and the specificity of the assay.
mRNA abundance analysis by real-time quantitative RT-PCR. Total RNA was extracted from tissues (ϳ20 mg) using TRIzol reagent (Life Technologies, Grand Island, NY), following manufacturer's instructions and treated with RQ1-DNase (Promega), and RNA quantity and quality were evaluated by spectrophotometry (NanoDrop 2000). Two micrograms of total RNA were reverse transcribed into cDNA using Superscript II reverse transcriptase (Promega, Madison, WI) and random hexaprimers (Promega). Gene expression levels were determined by real-time quantitative RT-PCR (q-PCR) using the iCycler iQ (Bio-Rad, Hercules, CA). Analyses were performed on 5 l of diluted (1/50) cDNA using the MAXIMA SYBR Green qPCR Mastermix (Life Technologies), in a total PCR reaction volume of 15 l, containing 120 -500 nM of each primer. Sequences of the forward and reverse primers used for each gene expression assay are shown in Table 1 . Relative quantification of the target genes was done using elongation factor 1 alpha (ef1a) or ubiquitin (ubq) as reference genes (16) . Thermal cycling was initiated with incubation at 95°C for 2 min using hot-start iTaq DNA polymerase activation; 35 steps of qPCR were performed, each one consisting of heating at 95°C for 15 s, 30 s at each specific annealing temperature (Table 1) , and 30 s at 72°C. Following the final PCR cycle, melting curves were systematically monitored (temperature gradient at 0.5°C/s from 55 to 94°C) to ensure that only one fragment was amplified. Samples without reverse transcriptase and samples without cDNA were run as negative controls, which were indeed negative and confirmed no amplification of genomic DNA. Relative expression of the target genes was calculated using the delta-delta CT method (2 Ϫ⌬⌬CT ), following Pfaffl (40) .
Statistics. Comparisons among groups were carried out using the statistical package SigmaStat with one-way ANOVA with treatment (control, SA, OA, ALA, and EPA) as the main factor. In cases where a significant effect was noted, post hoc comparisons were carried out by a Student-Newman-Keuls test. Differences were considered statistically significant at P Ͻ 0.05. Table 2 .
RESULTS
Fatty acid composition of hypothalamus from fish treated with intraperitoneal injections is shown in
All fish treated with FAs tended to have a lower food intake compared with the control group, although no significant differences were observed among treatments (Fig. 1) .
Concentrations of total FA in plasma increased in the SA and EPA groups ( Fig. 2A) compared with the control. In the hypothalamus, total FA levels (Fig. 2B ) increased in the OA treatment compared with the control and SA treatments and were also higher in fish injected with ALA compared with the control, SA, and EPA treatments. Triglyceride levels (Fig. 2C) were higher in the OA, ALA, and EPA treatments compared with the control and SA groups. Total lipid levels (Fig. 2D) were higher in the ALA group compared with control and SA groups. ACLY activity (Fig. 2E ) decreased in the OA and ALA groups compared with the control, and the activity in the ALA group was also lower than in the SA group. CPT-1 activity (Fig. 2F ) decreased in OA and ALA groups compared with the control.
The mRNA abundance of genes related to FA metabolism is shown in Fig. 3 . The expression of acc (Fig. 3A) decreased in the OA and ALA groups compared with the control. acly expression in the ALA group was lower than that of the control group (Fig. 3B) . fas mRNA abundance was lower in the OA group compared with the control (Fig. 3C) . The expression of cpt1.3 was higher in the SA and EPA groups compared with the control (Fig. 3F) . Finally, no significant changes were observed in mRNA abundance of cpt1.1 (Fig. 3D ) and cpt1.2 (Fig. 3E) .
Transcript levels of genes related to FA transport and regulation of gene expression (transcription factors) are shown in Fig. 4 . Transcription of fat/cd36-like genes, thrombospondin receptor or platelet glycoprotein 4-like (pg4l) (Fig. 4A) , and lysosome membrane protein 2-like (lmp2) (Fig. 4B) was not affected by any FA treatment. lxr␣ mRNA abundance (Fig.  4C) was decreased in the OA and EPA groups compared with the control group. Expression of ppar␣ (Fig. 4D) and srebp1c (Fig. 4E ) was lower in OA and ALA groups compared with the control.
The parameters related to mitochondrial activity and K ATP channel are shown in Fig. 5. HOAD activity (Fig. 5A ) in the OA and EPA groups was lower than that of the control and SA groups. On the other hand, the OA and ALA groups displayed a lower expression of kir6.x (Fig. 5B) and sur (Fig. 5C ) than the control.
The mRNA abundance of neuropeptides involved in the regulation of food intake is shown in Fig. 6 . Agrp2 expression in the OA group was lower than in the control, SA, and EPA groups, while in the ALA group, it was only lower than the control (Fig. 6A) . No significant changes were noted for mRNA abundance of npy (Fig. 6B) , pomca (Fig. 6C) , pomcb (Fig. 6D) , and cart4 (Fig. 6F) . cart2b mRNA levels (Fig. 6E) were higher in the OA, ALA, and EPA groups, whereas the expression in the EPA group was also higher than in the SA group.
DISCUSSION
We have previously demonstrated in rainbow trout, a freshwater fish species, the presence of FA sensing systems in the hypothalamus and their response to increased levels of OA or octanoate (22) (23) (24) (25) (26) (27) (28) (29) (30) . However, there was no evidence to date of the existence of such mechanisms in other fish species. PUFAs are a major constituent of marine fish diets, particularly important essential nutrients, and major constituents of fish brains and other body tissues. Therefore, we wanted to further investigate whether (if present) FA sensing systems in the hypothalamus of a marine fish species could respond to changes in PUFA levels, as well as to different types of LCFA differing in chain length and degree of saturation.
First of all, it was necessary to set up the techniques required for the evaluation of parameters related to FA sensing systems, including enzyme activities and gene expression in Senegalese sole. In some cases, multiple transcripts were found for the genes of interest, and preliminary work was performed to select those that would be more relevant for the objectives of this study. Thus, in the case of cart, seven different transcripts were found (5), of which we selected cart2b and cart4 to examine in this study. The first gene is the closest homolog to the trout cart that has been studied so far (22) and also to medaka ch3, which was the only cart transcript (out of six) that responded to fasting and refeeding in this species, and was suggested to have an anorexic role (39) . On the other hand, cart4 was selected because it is expressed relatively well in Senegalese sole hypothalamus and appears to respond to feeding (5) . On the other hand, we found five different transcripts for cpt1 (two of them being splice variants of the same gene: isoform 4), of which we decided to assess the three most similar to the trout cpt1 isoforms involved in FA sensing (22) . Finally, we also obtained evidence for the presence of multiple fat/cd36 genes, of which we focused on LMP2 and PG4L. The first gene resembled the transcript most commonly studied in relation to FA sensing in trout (22) , while the second is closest to a mammalian fat/cd36-like gene with roles in the orosensory detection of FA and mediating effects of FA on hypothalamic food intake regulation in rats (13, 19, 37) . The parameters related to the FA sensing system based on FA metabolism displayed changes depending on the FA assessed, and we clearly distinguished two patterns of response. The first pattern included the actions of OA and ALA that activated this system, as demonstrated by the decrease observed in ACLY activity and expression, CPT-1 activity, fas mRNA abundance (only after OA treatment), and acc expression. The response of these parameters is generally comparable to that previously observed in rainbow trout (22, 24, 26) and in mammals (8, 31) in response to OA, thus supporting the presence of this system in a marine fish species like Senegalese sole. The lack of changes in mRNA abundance of the different isoforms tested for CPT1 might indicate a failure in selecting the isoform in this species functionally similar to the CPT1c in rainbow trout (22) or mammals (7, 31) , in responding to changes in FA levels.
The response observed after ALA intraperitoneal injection, basically comparable to that of OA, suggest for the first time in any vertebrate species that this hypothalamic FA sensing system responds to increased levels of a n-3 PUFA differently to that observed to date in mammals (14, 15, 41) . There are no other studies that we are aware of in fish hypothalamus. The effects of n-3 PUFA like ALA, EPA, and DHA have only been elucidated in peripheral tissues such as the liver, where an inhibition of lipogenic enzymes (similar to that herein observed) has been recorded in rainbow trout (1, 35) .
The second pattern of response included the actions of SA and EPA, which, in general, did not induce any change in FA metabolism parameters, or the changes induced (e.g., increased expression of cpt1.3, similarly to the OA and ALA groups) were unexpected. The lack of response to SA is not surprising considering that in mammals, another saturated LCFA like palmitate did not induce changes in parameters related to this FA sensing system (41, 43) . This could mean that the response requires the presence of at least one double bond. On the other hand, the lack of changes observed in response to intraperitoneal injection of EPA is very interesting considering that this FA is also an n-3 PUFA (like ALA) but of a longer acyl chain and higher degree of saturation. We have no explanation for these differences. They could be associated with the fact that LC-PUFA (such as EPA and DHA) and C18 PUFA (such as ALA) may differentially affect key regulatory pathways of lipid metabolism, binding to nuclear receptors or transcription factors and modulating the expression of genes with different potencies, as has been observed in mammals (17, 51) . In this respect, a strong hypotriglyceridemic effect has been attributed to EPA in rats, through simultaneous effects on FA oxidation and lipogenic pathways (50) . In fish, this possibility has not been assessed yet. However, evidence supporting the existence of similar effects (at least in lipogenesis) is accumulating in Senegalese sole (6) and salmonid species (1, 33) . Gene expression results are expressed relative to the control group and are normalized by ef1␣ or ubq expression. Each value is the mean Ϯ SE of n ϭ 6 fish per treatment. Different lowercase letters above bars indicate significant differences (P Ͻ 0.05) between groups.
The FA sensing mechanisms based on binding of FA to FAT/CD36 and subsequent modulation of transcription factors was also differentially affected by FA treatments. Two fat/ cd36-like genes were investigated in Senegalese sole. The first one is the putative homolog of the gene that has been studied so far in trout (22, 24, 26) . The second one is closest to a mammalian fat/cd36 implicated in the orosensory detection of FA and affecting food intake through LCFA sensing in the hypothalamus (13, 19, 37) . However, no changes were observed in the mRNA abundance of any of the genes after treatment with the tested FA. Because other fat/cd36-like genes were identified in the transcriptomic SoleaDB (http://www.juntadeandalucia.es/agriculturaypesca/ifapa/soleadb_ifapa/), these should also be investigated in the future. If we focus on the remaining parameters related to this FA sensing system (mRNA abundance of ppar␣, srebp1c, and lxr␣), we can observe a similar response to that outlined above. Both OA and ALA altered the mRNA abundance of the transcription factors lxr␣ (although not ALA in this case), srebp1c, and ppar␣ in a way comparable to that previously observed after OA treatment in mammals (20, 21, 32) and rainbow trout (22, 24, 26) . These results support once again the presence of these mechanisms in the hypothalamus of Senegalese sole, as well as its response not only to an unsaturated C18 FA such as OA, but also to a C18 PUFA such as ALA. As far as we are aware, the response to an n-3 PUFA is absolutely novel in any vertebrate species to date. Very few studies exist in fish, although when Atlantic salmon were fed a DHA-enriched diet, no changes were observed in lxr␣ expression, while srebp1c was upregulated in whole brain tissue (4) . In spite of a trend for lower expression of these transcription factors in the SA and EPA treatments in relation to the control group, these changes were not significant. A notable exception was lxr␣, for which intraperitoneal injection with EPA, and not ALA, induced a significant downregulation.
The assessed parameters of FA sensing based on mitochondrial activity also displayed a generally similar pattern to the other FA sensing systems. The intraperitoneal injection of OA and ALA induced changes (decreased expression of the components of the K ATP channel and HOAD activity, although only significantly for OA in the latter case) comparable to those observed in rainbow trout (22, 24, 26) and in mammals (2, 8) after treatment with OA. In contrast, neither SA nor EPA induced any change in the mRNA levels of kir6.x or sur, but the EPA treatment led to a significant reduction of HOAD activity, compared with the control.
The activation of FA sensing systems is typically associated with the inhibition of the orexigenic factors AgRP and NPY, and the enhancement of the anorexigenic factors POMC and CART, ultimately leading to decreased food intake in mammals (8, 32) , as well as in rainbow trout (22, 26) . In Senegalese sole, intraperitoneal injections of both OA and ALA induced a decrease in the mRNA abundance of agrp2 and an increase in the mRNA abundance of cart2b (which was also significantly increased by the EPA treatment), without significantly affecting npy or pomc mRNA abundance. These changes in gene expression are consistent with a general anorexigenic balance that is usually associated with decreases in food intake, as observed in mammals (8, 10) or rainbow trout (22, 26) after treatment with OA. Furthermore, similar changes in anorexigenic potential have also been recorded in rat, after treatment with DHA (43), or after feeding an n-3 PUFA enriched-diet (11), while palmitate failed to induce effects in neuropeptide expression (43) , as was the case with SA in the current study. However, despite a slight decrease observed in food intake, nonsignificant differences in food intake were observed after FA treatment.
Perspectives and Significance
In summary, in the present study, we demonstrated that the three FA sensing systems characterized in rainbow trout are also present in Senegalese sole hypothalamus, indicating that (HOAD; A) , and mRNA abundance of kir6.x (B) and sur (C) in the hypothalamus of Senegalese sole 3 h after intraperitoneal administration of saline alone (CTR) or containing 300 g/kg of SA, OA, ALA, or EPA. Gene expression results are expressed relative to the control group and are normalized by ef1␣ or ubq expression. Each value is the mean Ϯ SE of n ϭ 12 (enzyme activity) or n ϭ 6 (mRNA levels) fish per treatment. Different lowercase letters above bars indicate significant differences (P Ͻ 0.05) between groups. this capacity is not specific to rainbow trout and can also be found in marine fish species like Senegalese sole. These systems were activated by OA in a way similar to that previously described not only in rainbow trout but also in mammals, highlighting their importance in the phylogeny of vertebrates. On the other hand, we provide for the first time in any vertebrate species (as far as we are aware) evidence of the activation of these hypothalamic FA sensing systems by an n-3 PUFA such as ALA. This is different from that reported in mammals (12, 13, 39, 41) . This different response may relate to the importance of n-3 PUFA in fish, especially in marine species. Thus, PUFA may be sensed in the hypothalamus of marine fish and possibly promote changes in food intake. However, in spite of the particularly high levels of LC-PUFA (including EPA) found in the brain tissues of teleosts, the overall lack of effects of EPA on fatty acid sensing systems in the hypothalamus of Senegalese sole indicates that the response might be specific to certain PUFA. This differential response may be related to different (yet undetermined) roles of LC-PUFA in fish. Still, intraperitoneal injections of EPA led to a few changes in some of the assessed parameters, such as increased plasma triglyceride levels and hypothalamic cpt1.3 and cart2b expression, and decreased lxr␣ mRNA levels and HOAD activity. These effects are probably unrelated to a role in FA sensing and might be explained by other mechanisms, such as the activation of transcription factors and modulation of the expression of lipid metabolism genes with effects on energy homeostasis. Finally, we also obtained evidence on the lack of a response of FA sensing systems to a saturated FA such as SA. This response is comparable to the lack of effect in mammals of other saturated LCFA, such as palmitate (15, 41) . However, we previously observed that a MCFA-like octanoate was able to activate these systems in rainbow trout. Therefore, both the level of unsaturation and chain length of FA seem to be important factors for the hypothalamic sensing capacity in sole but are probably not the only factors involved. 
